Measuring of advanced glycation end products in acute stroke care: skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitus
Background: Patients with diabetes mellitus (DM) are known to show poor recovery after stroke. This specific burden might be due to acute and chronic hyperglycemic effects. Meanwhile, the underlying mechanisms are a cause of discussion, and the best measure to predict the outcome is unclear. Skin au...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
15 March 2022
|
| In: |
Journal of Clinical Medicine
Year: 2022, Jahrgang: 11, Heft: 6, Pages: 1-9 |
| ISSN: | 2077-0383 |
| DOI: | 10.3390/jcm11061625 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/jcm11061625 Verlag, kostenfrei, Volltext: https://www.mdpi.com/2077-0383/11/6/1625 
|
| Verfasserangaben: | Alexandra Filipov, Heike Fuchshuber, Josephine Kraus, Anne D. Ebert, Vesile Sandikci and Angelika Alonso |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1885933193 | ||
| 003 | DE-627 | ||
| 005 | 20240703165007.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240416s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/jcm11061625 |2 doi | |
| 035 | |a (DE-627)1885933193 | ||
| 035 | |a (DE-599)KXP1885933193 | ||
| 035 | |a (OCoLC)1443669066 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Filipov, Alexandra |d 1987- |e VerfasserIn |0 (DE-588)1153639386 |0 (DE-627)1015139620 |0 (DE-576)500363056 |4 aut | |
| 245 | 1 | 0 | |a Measuring of advanced glycation end products in acute stroke care |b skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitus |c Alexandra Filipov, Heike Fuchshuber, Josephine Kraus, Anne D. Ebert, Vesile Sandikci and Angelika Alonso |
| 246 | 1 | |i Titel des übergeordneten Special issue |a Clinical research on type 2 diabetes and its complications | |
| 264 | 1 | |c 15 March 2022 | |
| 300 | |a 9 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 16.04.2024 | ||
| 520 | |a Background: Patients with diabetes mellitus (DM) are known to show poor recovery after stroke. This specific burden might be due to acute and chronic hyperglycemic effects. Meanwhile, the underlying mechanisms are a cause of discussion, and the best measure to predict the outcome is unclear. Skin autofluorescence (SAF) reflects the in-patient load of so-called advanced glycation end products (AGEs) beyond HbA1c and represents a valid and quickly accessible marker of chronic hyperglycemia. We investigated the predictive potential of SAF in comparison to HbA1c and acute hyperglycemia on the functional outcome at 90 days after ischemic stroke in a cohort of patients with DM. Methods: We prospectively included 113 patients with DM type 2 hospitalized for acute ischemic stroke. SAF was measured on each patient’s forearm by a mobile AGE-Reader mu© in arbitrary units. HbA1c and the area under the curve (AUC) of the blood sugar profile after admission were assessed. Functional outcome was assessed via phone interview after 90 days. A poor outcome was defined as a deterioration to a modified Rankin Scale score ≥ 3. A good outcome was defined as a modified Rankin Scale score < 3 or as no deterioration from premorbid level. Results: Patients with a poor outcome presented with higher values of SAF (mean 3.38 (SD 0.55)) than patients with a good outcome (mean 3.13 (SD 0.61), p = 0.023), but did not differ in HbA1c and acute glycemia. In logistic regression analysis, age (p = 0.021, OR 1.24 [1.12-1.37]) and SAF (p = 0.021, OR 2.74 [1.16-6.46]) significantly predicted a poor outcome, whereas HbA1c and acute glycemia did not. Patients with a poor 90-day outcome and higher SAF experienced more infections (4.2% vs. 33.3% (p < 0.01)) and other various in-hospital complications (21.0% vs. 66.7% (p < 0.01)) than patients with a good outcome and lower SAF levels. Conclusions: SAF offers an insight into glycemic memory and appears to be a significant predictor of poor stroke outcomes in patients with DM exceeding HbA1c and acute glycemia. Measuring SAF could be useful to identify specifically vulnerable patients at high risk of complications and poor outcomes. | ||
| 650 | 4 | |a advanced glycation end products | |
| 650 | 4 | |a diabetes mellitus | |
| 650 | 4 | |a hyperglycemia | |
| 650 | 4 | |a poststroke complications | |
| 650 | 4 | |a skin autofluorescence | |
| 650 | 4 | |a stroke outcome | |
| 700 | 1 | |a Fuchshuber, Heike |d 1993- |e VerfasserIn |0 (DE-588)1326326511 |0 (DE-627)1885934165 |4 aut | |
| 700 | 1 | |a Kraus, Josephine |e VerfasserIn |0 (DE-588)1313608319 |0 (DE-627)1876064625 |4 aut | |
| 700 | 1 | |a Ebert, Anne |d 1971- |e VerfasserIn |0 (DE-588)122028635 |0 (DE-627)081691998 |0 (DE-576)175098344 |4 aut | |
| 700 | 1 | |a Sandikci, Vesile |d 1988- |e VerfasserIn |0 (DE-588)1091117853 |0 (DE-627)852276427 |0 (DE-576)46128524X |4 aut | |
| 700 | 1 | |a Alonso, Angelika |d 1977- |e VerfasserIn |0 (DE-588)1025166795 |0 (DE-627)721355315 |0 (DE-576)370025865 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of Clinical Medicine |d Basel : MDPI, 2012 |g 11(2022), 6, Artikel-ID 1625, Seite 1-9 |h Online-Ressource |w (DE-627)718632478 |w (DE-600)2662592-1 |w (DE-576)365782718 |x 2077-0383 |7 nnas |a Measuring of advanced glycation end products in acute stroke care skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitus |
| 773 | 1 | 8 | |g volume:11 |g year:2022 |g number:6 |g elocationid:1625 |g pages:1-9 |g extent:9 |a Measuring of advanced glycation end products in acute stroke care skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitus |
| 856 | 4 | 0 | |u https://doi.org/10.3390/jcm11061625 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/2077-0383/11/6/1625 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20240416 | ||
| 993 | |a Article | ||
| 994 | |a 2022 | ||
| 998 | |g 1025166795 |a Alonso, Angelika |m 1025166795:Alonso, Angelika |d 60000 |d 62700 |e 60000PA1025166795 |e 62700PA1025166795 |k 0/60000/ |k 1/60000/62700/ |p 6 |y j | ||
| 998 | |g 1091117853 |a Sandikci, Vesile |m 1091117853:Sandikci, Vesile |d 60000 |d 62700 |e 60000PS1091117853 |e 62700PS1091117853 |k 0/60000/ |k 1/60000/62700/ |p 5 | ||
| 998 | |g 122028635 |a Ebert, Anne |m 122028635:Ebert, Anne |d 60000 |d 62700 |e 60000PE122028635 |e 62700PE122028635 |k 0/60000/ |k 1/60000/62700/ |p 4 | ||
| 998 | |g 1313608319 |a Kraus, Josephine |m 1313608319:Kraus, Josephine |d 60000 |e 60000PK1313608319 |k 0/60000/ |p 3 | ||
| 998 | |g 1326326511 |a Fuchshuber, Heike |m 1326326511:Fuchshuber, Heike |d 60000 |e 60000PF1326326511 |k 0/60000/ |p 2 | ||
| 999 | |a KXP-PPN1885933193 |e 4512496610 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"1885933193","titleAlt":[{"title":"Clinical research on type 2 diabetes and its complications"}],"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"15 March 2022"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"id":{"doi":["10.3390/jcm11061625"],"eki":["1885933193"]},"name":{"displayForm":["Alexandra Filipov, Heike Fuchshuber, Josephine Kraus, Anne D. Ebert, Vesile Sandikci and Angelika Alonso"]},"note":["Gesehen am 16.04.2024"],"language":["eng"],"person":[{"display":"Filipov, Alexandra","role":"aut","family":"Filipov","given":"Alexandra"},{"display":"Fuchshuber, Heike","role":"aut","family":"Fuchshuber","given":"Heike"},{"given":"Josephine","family":"Kraus","role":"aut","display":"Kraus, Josephine"},{"role":"aut","display":"Ebert, Anne","given":"Anne","family":"Ebert"},{"given":"Vesile","family":"Sandikci","role":"aut","display":"Sandikci, Vesile"},{"family":"Alonso","given":"Angelika","display":"Alonso, Angelika","role":"aut"}],"physDesc":[{"extent":"9 S."}],"relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title":"Journal of Clinical Medicine","subtitle":"open access journal","title_sort":"Journal of Clinical Medicine"}],"note":["Gesehen am 12.06.20"],"disp":"Measuring of advanced glycation end products in acute stroke care skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitusJournal of Clinical Medicine","id":{"eki":["718632478"],"zdb":["2662592-1"],"issn":["2077-0383"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"part":{"issue":"6","pages":"1-9","text":"11(2022), 6, Artikel-ID 1625, Seite 1-9","volume":"11","extent":"9","year":"2022"},"pubHistory":["1.2012 -"],"recId":"718632478","origin":[{"dateIssuedKey":"2012","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2012-"}]}],"title":[{"subtitle":"skin autofluorescence as a predictor of ischemic stroke outcome in patients with diabetes mellitus","title":"Measuring of advanced glycation end products in acute stroke care","title_sort":"Measuring of advanced glycation end products in acute stroke care"}]} | ||
| SRT | |a FILIPOVALEMEASURINGO1520 | ||